Report cover image

Global Medical Aesthetics Market Size, Trend & Opportunity Analysis Report, by Procedure Type (Invasive Procedures (Breast augmentation, Liposuction, Nose reshaping, Eyelid Surgery, Tummy tuck, Others), Non-invasive Procedures (Botox injections, Soft tiss

Published Oct 22, 2025
Length 285 Pages
SKU # KAIS20696452

Description

Market Definition and Introduction

The global medical aesthetics market was valued at USD 89.55 billion in 2024 and is anticipated to reach USD 221.92 billion by 2035, expanding at a CAGR of 8.60% during the forecast period (2024–2035). Aesthetic awareness is rapidly increasing across developing and developed economies, leading to unprecedented transformations in the global medical aesthetic industry. The populace for the first time seeks cosmetic enhancement, not just for elevating vanity but for wellness ideals associated with self-confidence and ageing. This is primarily why clinics, medspas, and dermatology chains are now diversifying combinations of client investigations: the science, artistry, and advanced medical technology applications. Their lines increasingly carry procedures like injectables, laser therapy, body contouring, and minimally invasive surgical interventions that mainstream over democratized affordability and social acceptability.

Patients increasingly prefer non-invasive methods, consumers search for rapid recovery, little downtime, and natural-looking results in their procedures. However, the exact opposite is true for some groups of patients, who still like invasive techniques to give them dramatic, long-lasting effects. Both patterns of growth thus spur the device manufacturers and pharmaceutical companies to innovate ceaselessly-they do so by creating the right balance between efficacy and safety associated with patient comfort. Further, digitalisation in patient consultation journeys through AI-based diagnostic tools and personalised treatment mapping is yet another enrichment mark on the growth trajectory of the sector.

Characterised by a competitive landscape consisting of bold product launches, strategic alliances, and robust investments into the R&D pipelines regarding novel energy-based devices, regenerative medicine therapies, and advanced injectables. Regulatory pressure combined with technological sophistication is triggering stakeholders to rethink innovation strategies along with benchmarking safety standards. As demography changes towards ageing populations with increased spending on aesthetic preventive care by millennials, this is the most lucrative financial era for the medical aesthetics industry.

Recent Developments in the Industry

In March 2024, AbbVie announced portfolio enhancements in the Botox & Juvederm lines, strengthening its strength in minimally invasive aesthetics with extended global distribution.

In May 2024, Lumenis introduced the Stellar M22™, a next-generation multi-application platform for skin rejuvenation, hair removal, and vascular treatments, expanding physician capabilities.

In August 2023, Cutera Inc. received the cold FDA approval for the TruBody®, an advanced non-invasive body sculpting system that combines fat reduction with muscle enhancement protocols.

February of 2025 saw Cynosure LLC picnic under the laudable roofs of leading dermatology networks to have the AI-powered diagnostic software embedded into its energy-based aesthetic devices.

In October 2024, Alma Lasers inaugurated a training and education hub in Dubai, with the aim of accelerating clinician proficiency in energy-based and regenerative aesthetic solutions.

Market Dynamics

Rising demand for minimally invasive procedures propels global market expansion.

Increasing interest in non-invasive Botox, dermal fillers, and laser treatment options has a direct correlation with increasing growth rates for these treatments. The minimal recovery is enough to attract a younger generation and the older retiree seeking natural enhancement.

Growing ageing population drives aesthetic procedure adoption worldwide

As the elderly population rises globally, so does the need for treatments that defy ageing, such as wrinkle reduction, skin tightening, and regenerative medicine therapies. This population shift will invariably raise demand for aesthetic procedures, invasive and noninvasive.

Technological innovation reshapes competitive dynamics in the aesthetics industry.

Laser systems, radiofrequency devices, cryolipolysis, and injectables are now continuously advancing, increasing clinical efficacy while ensuring safety. Digital treatment simulation and AI-based diagnostics create a novel patient experience, empowering clinics to thus distinguish and capture premium clientele.

Costly Treatments and Regulatory Complexities Restrain the Market

Though affordable, demand is strong, but the still sensitive economies have a significant limitation in terms of access. In addition, new device approval in most cases is hindered by very strict regulations and long timelines, further restricting their commercial rollouts.

Medical tourism and expanding clinic networks create lucrative opportunities.

Emerging economies, especially those in the Asia-Pacific region and in the Middle East, are capitalising on medical tourism by offering aesthetic procedures that are both affordable and sophisticated. Apart from those, the proliferation of medspas and cross-border clinic chains may even emerge to discover new revenue opportunities for device and injectable manufacturers.

Attractive Opportunities in the Market

Regenerative Aesthetic Therapies – Surge in stem cell and PRP-based procedures boosts natural rejuvenation demand
AI-Powered Treatment Planning – Integration of diagnostics software enhances precision and personalisation in patient care
Medical Tourism Growth – Affordable, high-quality treatments in Asia-Pacific attract international patient flows
Male Aesthetic Procedures – Increasing uptake of body contouring and injectables among male demographics worldwide
Hybrid Clinics Expansion – Dermatology and wellness clinics blending medspa aesthetics to cater to broader patient bases
Laser & Energy Device Boom – Rising adoption of energy-based treatments for skin tightening and fat reduction
E-commerce Skincare Integration – Aesthetic brands expanding digital channels for post-procedure maintenance products
Ageing Population Demand – Expanding geriatric groups drive wrinkle, skin-lift, and regenerative treatments
Non-Invasive Procedure Preference – Patient shift towards low-downtime treatments accelerates market momentum
Cross-Border Partnerships – Collaborations between clinics and global suppliers enhance training and technology diffusion

Report Segmentation

By Procedure Type:
Invasive Procedures (Breast augmentation, Liposuction, Nose reshaping, Eyelid Surgery, Tummy tuck, Others)
Non-invasive Procedures (Botox injections, Soft tissue fillers, Chemical peel, Laser hair removal, Microdermabrasion, Others)

By End Use: Hospitals, Clinics & Aesthetic Centers, Medspas

By Type of Device: Standalone Devices, Multimodal Devices, At-Home/Self-Use Devices

By Region: North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), LAMEA (Brazil, Argentina, UAE, Saudi Arabia (KSA), Africa Rest of Latin America)

Key Market Players

AbbVie Inc., Lumenis Ltd., Cutera Inc., Cynosure LLC, Alma Lasers, Evolus Inc., Candela Corporation, Bausch Health Companies Inc., Revance Therapeutics Inc., and Allergan Aesthetics.

Report Aspects

Base Year: 2024
Historic Years: 2022, 2023, 2024
Forecast Period: 2024-2035
Report Pages: 293

Dominating Segments

Convenience and as well as becoming socially accepted drive the non-invasive dominating procedures in the market.

Injectable botulinum toxins, dermal fillers, and energy-based therapies qualify as the fastest-growing segment of the thriving non-invasive procedures available today, which tend to dominate for the reasons of minimal downtime and almost instantaneous results. All the clinics are offering radiofrequency and laser systems worldwide. The consumer interest or need for subtle enhancements guarantees speedy results. Millennials are also giving them an ear, seeing them instead as preventive anti-ageing methods, not corrective measures.

Surgery is still crucial in patients seeking long-lasting outcomes.

Noninvasive treatments have increased in speed, but long, invasive operations, such as facelift, liposuction, and breast augmentation, will also be very important to patients wanting dramatic alterations. Under the latest advances in technology, surgical procedures are now less time-consuming, safer, and more aesthetically pleasing. This category will still generate a strong return, particularly in North America and Europe, where disposable incomes are high and the tendency to spend more on whole treatments is greater.

Injections in aesthetics spearhead the assault of the newly defined standards of beauty for consumers worldwide.

Injectables, especially botulinum toxins and dermal fillers, have democratised medical aesthetic procedures by making them affordable, accessible, and effective. With AbbVie, Revance, and Evolus leading very aggressive product expansions into this area, injectables have become the entry door for the fresh patients who have just stepped into the aesthetics market. The demand for the natural yet contoured faces, fuller lips, and fewer wrinkles makes this category the growth engine of aesthetics.

Energy-based devices create new standards for precision-driven aesthetic solutions.

Laser, ultrasound, and radiofrequency devices have gained a reputation as the high-end tools employed to rejuvenate skin, contour the body, and provide hair removal. Continued innovations by Lumenis, Alma, and Cynosure will ensure that practitioners will have versatile systems to address multiple concerns all at once. They sit in the middle between invasive and very much noninvasive applications, guaranteeing a steady revenue stream and increasing adoption across both premium and mid-tier clinics.

Key Takeaways

Injectables Surge Ahead – Botox and fillers continue to redefine beauty and anti-ageing across demographics
Non-Invasive Popularity – Patient preference for low-downtime treatments cements the growth of energy-based systems
Surgical Procedures Hold – Liposuction and facelifts retain importance in high-income consumer groups
Male Market Growth – Uptake of body contouring and skin treatments among male patients is expanding rapidly
AI Integration Rising – Diagnostic software enhances precision and patient satisfaction in treatment planning
Medical Tourism Hotspots – Asia-Pacific and the Middle East attract global patients with affordable, quality treatments
Regenerative Therapies Rising – Stem cell and platelet-rich plasma-based procedures open new treatment pathways
Clinic Consolidation Trend – Expanding medspa chains dominate urban markets, reshaping competition dynamics
Digital Aftercare Expansion – Skincare brands offer online product ecosystems for treatment sustainability
Ageing Population Drivers – Global geriatric growth sustains demand for wrinkle, tightening, and rejuvenation procedures

Regional Insights

Best source for analysing the impact of the North American market, promoting technological initiatives and consumer expenditure power.

Global dominance in medicine and beauty aesthetic economy goes by the demand from both invasive and non-invasive methods. The United States continues to be the heart of innovation, with high disposable incomes, clinical infrastructure, and favourable regulatory approvals. AbbVie and Cutera are not the only companies producing new products; however, the elderly population and social media influences in the region are now building more and more appeal among the younger groups.

Europe is speeding up the green and ethical innovation in medical aesthetics.

Emerging as yet another very strong growth region in Europe are Germany, France, and the United Kingdom, leading the adoption of both non-invasive and invasive technologies. Safety, ethics, and sustainability in the region encourage companies to invent eco-conscious technologies such as energy-efficient devices and biodegradable injectables. Clinics increasingly adopt regenerative medicine techniques alongside legal global frameworks that emphasise patient safety and ethical practice in medicine.

Asia-Pacific turns out to be the fastest-growing area in aesthetics adoption.

Asia-Pacific is number one in the growth trajectory, propelled by rapid urbanisation, increases in disposable income by the emerging middle-class, and booming medical tourism. China, India, and South Korea have taken the lead in adopting this trend, driven by government investment in infrastructure for advanced clinics and enhancing surgeon expertise. The growing cosmetic surgery culture in South Korea and affordability in India are already positioning the region as the world's aesthetic destination, attracting cross-border flows of patients.

LAMEA becomes a hub for medical tourism and future networked clinics

The LAMEA region, especially the UAE, Brazil, and Saudi Arabia, is becoming a promising medical aesthetics hub. The development of healthcare infrastructure, coupled with increasing acceptance of aesthetics by young consumers and the establishment of newer, more specialised clinics, is driving demand. Brazil tops in surgical aesthetics, while the Middle East is leveraging on luxurious medical tourism packages and positioning itself as a top destination for the best in aesthetic care.

Core Strategic Questions Answered in This Report

What is the expected growth trajectory of the medical aesthetics market from 2024 to 2035?

The global medical aesthetics market is projected to grow from USD 89.55 billion in 2024 to USD 221.92 billion by 2035, registering a CAGR of 8.6%. This growth is driven by heightened adoption of non-invasive procedures, technological advancements, and expanding medical tourism.

Q. Which key factors are fuelling the growth of the medical aesthetics market?

Several key factors are propelling market growth:

Rising demand for non-invasive and minimally invasive procedures globally
Expanding disposable incomes and growing awareness of aesthetic wellness
Technological innovations in injectables and energy-based systems
Growth of medical tourism, particularly in the Asia-Pacific and the Middle East
Expanding clinic chains and digital consultation platforms are increasing accessibility

Q. What are the primary challenges hindering the growth of the medical aesthetics market?

Major challenges include:

High procedure costs are restricting adoption in low-income markets
Stringent regulatory frameworks are delaying product approvals
Limited availability of skilled professionals in emerging markets
Patient safety concerns regarding unregulated cosmetic clinics
Economic fluctuations affecting discretionary spending

Q. Which regions currently lead the medical aesthetics market in terms of market share?

North America currently leads the medical aesthetics market due to advanced technology adoption and high consumer spending power. Europe closely follows with regulatory-driven innovation, while Asia-Pacific represents the fastest-growing region.

Q. What emerging opportunities are anticipated in the medical aesthetics market?

The market is ripe with new opportunities, including:

Rising demand for regenerative and cell-based therapies
Expanding adoption of AI-integrated diagnostic platforms
Growth in medical tourism across the Asia-Pacific and the Middle East
Innovative non-invasive body contouring solutions
Expanding the male patient segment for aesthetic procedures

Key Benefits for Stakeholders

The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
A detailed examination of market segmentation helps identify existing and emerging opportunities.
Key countries within each region are analysed based on their revenue contributions to the overall market.
The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion.

Table of Contents

285 Pages
Chapter 1. Market Snapshot
1.1. Market Definition & Report Overview
1.2. Market Segmentation
1.3. Key Takeaways
1.3.1. Top Investment Pockets
1.3.2. Top Winning Strategies
1.3.3. Market Indicators Analysis
1.3.4. Top Impacting Factors
1.4. Application Ecosystem Analysis
1.4.1. 360’ Analysis
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Market Attractiveness Analysis (top leader’s point of view on the market)
2.5. Key Findings
Chapter 3. Research Methodology
3.1. Research Objective
3.2. Supply Side Analysis
3.2.1. Primary Research
3.2.2. Secondary Research
3.3. Demand Side Analysis
3.3.1. Primary Research
3.3.2. Secondary Research
3.4. Forecasting Models
3.4.1. Assumptions
3.4.2. Forecasts Parameters
3.5. Competitive breakdown
3.5.1. Market Positioning
3.5.2. Competitive Strength
3.6. Scope of the Study
3.6.1. Research Assumption
3.6.2. Inclusion & Exclusion
3.6.3. Limitations
Chapter 4. Industry Landscape
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Porter’s 5 Forces Model
4.2.1. Bargaining Power of Buyer
4.2.2. Bargaining Power of Supplier
4.2.3. Threat of New Entrants
4.2.4. Threat of Substitutes
4.2.5. Competitive Rivalry
4.3. Value Chain Analysis
4.4. PESTEL Analysis
4.5. Pricing Analysis and Trends
4.6. Key growth factors and trends analysis
4.7. Market Share Analysis (2024)
4.8. Top Winning Strategies (2024)
4.9. Trade Data Analysis (Import Export)
4.10. Regulatory Guidelines
4.11. Historical Data Analysis
4.12. Analyst Recommendation & Conclusion
Chapter 5. Global Medical Aesthetics Market Size & Forecasts by Procedure Type 2024-2035
5.1. Market Overview
5.1.1. Market Size and Forecast By Procedure Type 2024-2035
5.2. Invasive Procedures
5.2.1. Breast augmentation
5.2.2. Liposuction
5.2.3. Nose reshaping
5.2.4. Eyelid Surgery
5.2.5. Tummy tuck
5.2.6. Others
5.3. Non-invasive Procedures
5.3.1. Botox injections
5.3.2. Soft tissue fillers
5.3.3. Chemical peel
5.3.4. Laser hair removal
5.3.5. Microdermabrasion
5.3.6. Others
Chapter 6. Global Matting Agents Market Size & Forecasts by End Use 2024-2035
6.1. Market Overview
6.1.1. Market Size and Forecast By End Use 2024-2035
6.2. Hospitals
6.2.1. Market definition, current market trends, growth factors, and opportunities
6.2.2. Market size analysis, by region, 2024-2035
6.2.3. Market share analysis, by country, 2024-2035
6.3. Clinics & Aesthetic Centers
6.3.1. Market definition, current market trends, growth factors, and opportunities
6.3.2. Market size analysis, by region, 2024-2035
6.3.3. Market share analysis, by country, 2024-2035
6.4. Medspas
6.4.1. Market definition, current market trends, growth factors, and opportunities
6.4.2. Market size analysis, by region, 2024-2035
6.4.3. Market share analysis, by country, 2024-2035
Chapter 7. Global Matting Agents Market Size & Forecasts by Type of Device 2024-2035
7.1. Market Overview
7.1.1. Market Size and Forecast By Type of Device 2024-2035
7.2. Standalone Devices
7.2.1. Market definition, current market trends, growth factors, and opportunities
7.2.2. Market size analysis, by region, 2024-2035
7.2.3. Market share analysis, by country, 2024-2035
7.3. Multimodal Devices
7.3.1. Market definition, current market trends, growth factors, and opportunities
7.3.2. Market size analysis, by region, 2024-2035
7.3.3. Market share analysis, by country, 2024-2035
7.4. At-Home/Self-Use Devices
7.4.1. Market definition, current market trends, growth factors, and opportunities
7.4.2. Market size analysis, by region, 2024-2035
7.4.3. Market share analysis, by country, 2024-2035
Chapter 8. Global Medical Aesthetics Market Size & Forecasts by Region 2024–2035
8.1. Regional Overview 2024-2035
8.2. Top Leading and Emerging Nations
8.3. North America Medical Aesthetics Market
8.3.1. U.S. Medical Aesthetics Market
8.3.1.1. Procedure Type breakdown size & forecasts, 2024-2035
8.3.1.2. End Use breakdown size & forecasts, 2024-2035
8.3.1.3. Type of Device breakdown size & forecasts, 2024-2035
8.3.2. Canada Medical Aesthetics Market
8.3.2.1. Procedure Type breakdown size & forecasts, 2024-2035
8.3.2.2. End Use breakdown size & forecasts, 2024-2035
8.3.2.3. Type of Device breakdown size & forecasts, 2024-2035
8.3.3. Mexico Medical Aesthetics Market
8.3.3.1. Procedure Type breakdown size & forecasts, 2024-2035
8.3.3.2. End Use breakdown size & forecasts, 2024-2035
8.3.3.3. Type of Device breakdown size & forecasts, 2024-2035
8.4. Europe Medical Aesthetics Market
8.4.1. UK Medical Aesthetics Market
8.4.1.1. Procedure Type breakdown size & forecasts, 2024-2035
8.4.1.2. End Use breakdown size & forecasts, 2024-2035
8.4.1.3. Type of Device breakdown size & forecasts, 2024-2035
8.4.2. Germany Medical Aesthetics Market
8.4.2.1. Procedure Type breakdown size & forecasts, 2024-2035
8.4.2.2. End Use breakdown size & forecasts, 2024-2035
8.4.2.3. Type of Device breakdown size & forecasts, 2024-2035
8.4.3. France Medical Aesthetics Market
8.4.3.1. Procedure Type breakdown size & forecasts, 2024-2035
8.4.3.2. End Use breakdown size & forecasts, 2024-2035
8.4.3.3. Type of Device breakdown size & forecasts, 2024-2035
8.4.4. Spain Medical Aesthetics Market
8.4.4.1. Procedure Type breakdown size & forecasts, 2024-2035
8.4.4.2. End Use breakdown size & forecasts, 2024-2035
8.4.4.3. Type of Device breakdown size & forecasts, 2024-2035
8.4.5. Italy Medical Aesthetics Market
8.4.5.1. Procedure Type breakdown size & forecasts, 2024-2035
8.4.5.2. End Use breakdown size & forecasts, 2024-2035
8.4.5.3. Type of Device breakdown size & forecasts, 2024-2035
8.4.6. Rest of Europe Medical Aesthetics Market
8.4.6.1. Procedure Type breakdown size & forecasts, 2024-2035
8.4.6.2. End Use breakdown size & forecasts, 2024-2035
8.4.6.3. Type of Device breakdown size & forecasts, 2024-2035
8.5. Asia Pacific Medical Aesthetics Market
8.5.1. China Medical Aesthetics Market
8.5.1.1. Procedure Type breakdown size & forecasts, 2024-2035
8.5.1.2. End Use breakdown size & forecasts, 2024-2035
8.5.1.3. Type of Device breakdown size & forecasts, 2024-2035
8.5.2. India Medical Aesthetics Market
8.5.2.1. Procedure Type breakdown size & forecasts, 2024-2035
8.5.2.2. End Use breakdown size & forecasts, 2024-2035
8.5.2.3. Type of Device breakdown size & forecasts, 2024-2035
8.5.3. Japan Medical Aesthetics Market
8.5.3.1. Procedure Type breakdown size & forecasts, 2024-2035
8.5.3.2. End Use breakdown size & forecasts, 2024-2035
8.5.3.3. Type of Device breakdown size & forecasts, 2024-2035
8.5.4. Australia Medical Aesthetics Market
8.5.4.1. Procedure Type breakdown size & forecasts, 2024-2035
8.5.4.2. End Use breakdown size & forecasts, 2024-2035
8.5.4.3. Type of Device breakdown size & forecasts, 2024-2035
8.5.5. South Korea Medical Aesthetics Market
8.5.5.1. Procedure Type breakdown size & forecasts, 2024-2035
8.5.5.2. End Use breakdown size & forecasts, 2024-2035
8.5.5.3. Type of Device breakdown size & forecasts, 2024-2035
8.5.6. Rest of APAC Medical Aesthetics Market
8.5.6.1. Procedure Type breakdown size & forecasts, 2024-2035
8.5.6.2. End Use breakdown size & forecasts, 2024-2035
8.5.6.3. Type of Device breakdown size & forecasts, 2024-2035
8.6. LAMEA Medical Aesthetics Market
8.6.1. Brazil Medical Aesthetics Market
8.6.1.1. Procedure Type breakdown size & forecasts, 2024-2035
8.6.1.2. End Use breakdown size & forecasts, 2024-2035
8.6.1.3. Type of Device breakdown size & forecasts, 2024-2035
8.6.2. Argentina Medical Aesthetics Market
8.6.2.1. Procedure Type breakdown size & forecasts, 2024-2035
8.6.2.2. End Use breakdown size & forecasts, 2024-2035
8.6.2.3. Type of Device breakdown size & forecasts, 2024-2035
8.6.3. UAE Medical Aesthetics Market
8.6.3.1. Procedure Type breakdown size & forecasts, 2024-2035
8.6.3.2. End Use breakdown size & forecasts, 2024-2035
8.6.3.3. Type of Device breakdown size & forecasts, 2024-2035
8.6.4. Saudi Arabia (KSA Medical Aesthetics Market
8.6.4.1. Procedure Type breakdown size & forecasts, 2024-2035
8.6.4.2. End Use breakdown size & forecasts, 2024-2035
8.6.4.3. Type of Device breakdown size & forecasts, 2024-2035
8.6.5. Africa Medical Aesthetics Market
8.6.5.1. Procedure Type breakdown size & forecasts, 2024-2035
8.6.5.2. End Use breakdown size & forecasts, 2024-2035
8.6.5.3. Type of Device breakdown size & forecasts, 2024-2035
8.6.6. Rest of LAMEA Medical Aesthetics Market
8.6.6.1. Procedure Type breakdown size & forecasts, 2024-2035
8.6.6.2. End Use breakdown size & forecasts, 2024-2035
8.6.6.3. Type of Device breakdown size & forecasts, 2024-2035
Chapter 9. Company Profiles
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. AbbVie Inc.
9.2.1.1. Company Overview
9.2.1.2. Key Executives
9.2.1.3. Company Snapshot
9.2.1.4. Financial Performance (Subject to Data Availability)
9.2.1.5. Product/Services Port
9.2.1.6. Recent Development
9.2.1.7. Market Strategies
9.2.1.8. SWOT Analysis
9.2.2. Lumenis Ltd.
9.2.3. Cutera Inc.
9.2.4. Cynosure LLC
9.2.5. Alma Lasers
9.2.6. Evolus Inc.
9.2.7. Candela Corporation
9.2.8. Bausch Health Companies Inc.
9.2.9. Revance Therapeutics Inc.
9.2.10. Allergan Aesthetics
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.